Kezar Life Sciences, Inc.
KZRDelisted May 11, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001645666
Kezar Life Sciences, Inc. was delisted on May 11, 2026; its insiders filed their last Form 4 on May 11, 2026; 43 institutions reported holding it in 13F filings for Q1 2026, worth $32.8M in total; no superinvestor held it.
Q3 2021 vs. Q2 2021
How the institutions holding Kezar Life Sciences, Inc. changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Q3 2021 | Change |
|---|---|---|---|
| Holders | 75 | 77 | +2 |
| Shares | 27.6M | 28.1M | +428.5K (+1.6%) |
| Value | $150.1M | $242.7M | +$92.6M (+61.7%) |
New holders (10)
Institutions that held Kezar Life Sciences, Inc. at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Avidity Partners Management LP | 260,000 | $2.25M | 0.06% |
| Martingale Asset Management L P | 26,119 | $226.0K | 0.00% |
| SG Americas Securities, LLC | 23,481 | $203.0K | 0.00% |
| Manufacturers Life Insurance Company, The | 14,363 | $124.0K | 0.00% |
| MetLife Investment Management | 12,936 | $111.8K | 0.00% |
| Metropolitan Life Insurance Co | 9,787 | $84.6K | 0.00% |
| Federated Hermes, Inc. | 6,734 | $58.0K | 0.00% |
| Meeder Asset Management Inc | 6,009 | $53.0K | 0.00% |
| Group One Trading, L.P. | 604 | $5.00K | 0.00% |
| Meridian Wealth Partners, LLC | 233 | $2.00K | 0.00% |
Sold out (8)
Institutions that held Kezar Life Sciences, Inc. at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Opaleye Management Inc. | 697,800 | $3.79M |
| Alyeska Investment Group, L.P. | 383,831 | $2.08M |
| First Trust Advisors LP | 96,456 | $524.0K |
| Gsa Capital Partners LLP | 88,919 | $483.0K |
| California Public Employees Retirement System | 15,564 | $85.0K |
| Retirement Capital Strategies | 15,000 | $81.0K |
| Panagora Asset Management Inc | 1,689 | $9.00K |
| Captrust Financial Advisors | 92 | $0 |